PAK5 and neoplasm: Nevertheless, the deep deletions observed for PAK5 and PAK6 in cancers such as pancreatic and prostate raise the possibility that these isoforms may function as tumor suppressors in certain contexts as has been suggested in hepatocellular carcinoma (Liu et al., 2015), a hypothesis that warrants further investigation.